Concepedia

R. Miserendino

RM

Statistics

Publications

1

Citations

209

H-Index

1

Active since

1999

Affiliations

Novartis (United States)(Current)

R. Miserendino is an author at Novartis (United States) specializing in medicine, peptidase activity, and impaired glucose tolerance.

Publications per year

1999–1999

1

Publications

1

Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats

Börk Balkan, L. Kwasnik, R. Miserendino et al. · Diabetologia · 1999 · 209 citations · Full text

, , +14

1–1 of 1